Preclinical Profile of the Monodisperse Iodinated Macromolecular Blood Pool Agent P743

Idée JM, Port M, Robert P, et al. Preclinical profile of the monodisperse iodinated macromolecular blood pool agent P743. Invest Radiol 2001;36:41–49. RATIONALE AND OBJECTIVES.To summarize the chemical synthesis, physicochemical characterization, pharmacokinetic behavior, and biological evaluation of P743, a new macromolecular iodinated contrast medium. METHODS.The synthesis and molecular modeling of the iodinated macromolecule P743 are described. The pharmacokinetic profile was established in rabbits and rats. Acute toxicity in mice, renal tolerance in normal rabbits, and renal tolerance in uninephrectomized, dehydrated rats undergoing selective intrarenal injection was evaluated. In vitro permeability effects on isolated mastocytes and on the coagulation pathways were carried out. Computed tomography vascular imaging was performed after intravenous injection of P743 (300 mg I/kg) in rabbits and compared with the nonspecific nonionic agent iobitridol. RESULTS.P743 is a monodisperse, macromolecular iodin ated contrast medium. In both rabbits and rats, P743 showed a pharmacokinetic profile consistent with that of a rapid-clearance blood-pool agent. Its diffusion through the endothelium was found to be low in vitro, thus confirming early confinement of this macromolecule, unlike nonspecific contrast media. In both species, P743 was excreted by glomerular filtration. Acute toxicity disclosed no mortality at the highest volume that could be injected into mice, leading to a median lethal dose greater than 8.9 g I/kg. Renal tolerance was found to be good in both euvolemic rabbits and uninephrectomized, dehydrated rats. No histamine or leukotriene B4 release was found on RBL-2H3 isolated mastocytes. P743 did not interfere with the coagulation pathways. Imaging experiments confirmed that P743 remains in the vascular compartment for a longer time than does iobitridol, thus allowing vascular enhancement that is twice as high as that of iobitridol in the recirculation phase. CONCLUSIONS.The pharmacokinetic and imaging profiles of P743, a new, monodisperse, macromolecular blood-pool iodinated contrast medium, were consistent with those of a rapid-clearance blood-pool agent. Its initial safety profile is satisfactory. Further experimental imaging studies are required to define the clinical interest in such molecules.

[1]  Isabelle Raynal,et al.  Physical, chemical, and biological evaluations of P760: A new gadolinium complex characterized by a low rate of interstitial diffusion , 2000, Journal of magnetic resonance imaging : JMRI.

[2]  H. Dvorak,et al.  VPF/VEGF and the angiogenic response. , 2000, Seminars in perinatology.

[3]  C. Corot,et al.  Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: pathophysiology and clinical aspects , 1999, Fundamental & clinical pharmacology.

[4]  C. Corot,et al.  In vitro evaluation of vascular permeability to contrast media using cultured endothelial cell monolayers. , 1999, Investigative radiology.

[5]  V. Trubetskoy,et al.  Polymeric micelles as carriers of diagnostic agents. , 1999, Advanced Drug Delivery Reviews.

[6]  H Hu,et al.  Multi-slice helical CT: scan and reconstruction. , 1999, Medical physics.

[7]  P. Gérard,et al.  Mechanisms of severe, immediate reactions to iodinated contrast material. , 1998, Radiology.

[8]  N. Simionescu,et al.  Experimental evaluation of the vascular effects and transport of an iodinated macromolecular contrast medium. , 1997, Investigative radiology.

[9]  J. Idee,et al.  Reliability of experimental models of iodinated contrast media-induced acute renal failure. From methodological considerations to pathophysiology. , 1996, Investigative radiology.

[10]  P. Leander.  A New Liposomal Contrast Medium for CT of the Liver , 1996 .

[11]  J. Greiner,et al.  Highly concentrated 1,2-bis(perfluoroalkyl) iodoethene emulsions for use as contrast agents for diagnosis , 1995 .

[12]  E F Halpern,et al.  Nanoparticulate computed tomography contrast agents for blood pool and liver-spleen imaging. , 1994, Academic radiology.

[13]  J. Idee,et al.  Iodinated contrast media‐induced nephropathy: pathophysiology, clinical aspects and prevention , 1994, Fundamental & clinical pharmacology.

[14]  C. de Haën,et al.  Toxicological safety assessment of iomeprol, a new X-ray contrast agent. , 1994, European journal of radiology.

[15]  G. Schuhmann-Giampieri,et al.  Characterization of Iopromide-Carrying Liposomes , 1994 .

[16]  M. Brezis.  Forefronts in nephrology: summary of the newer aspects of renal cell injury. , 1992, Kidney international.

[17]  B. Bonnemain,et al.  Blood‐Pool X‐Ray Contrast Agents: Evaluation of a New Iodinated Polymer , 1991, Investigative radiology.

[18]  C. Corot,et al.  Iodinated Polymer as Blood‐Pool Contrast Agent: Computed Tomography Evaluation in Rabbits , 1991, Investigative radiology.

[19]  F. Klocke,et al.  First‐Pass Entry of Nonionic Contrast Agent Into the Myocardial Extravascular Space: Effects on Radiographic Estimates of Transit Time and Blood Volume , 1991, Circulation.

[20]  P. Liebemman.  Anaphylactoid reactions to radiocontrast material. , 1991, Annals of allergy.

[21]  N. Simionescu,et al.  Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. , 1991, Cell biology reviews : CBR.

[22]  C. Corot,et al.  Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. , 1991, Clinical materials.

[23]  G. Deray,et al.  Renal effects of radiocontrast agents in rats: a new model of acute renal failure. , 1990, American journal of nephrology.

[24]  R. Bourbouze,et al.  Excretion of Urinary N-Acetyl-ß-D-glucosaminidase Isoenzymes after Renal Transplantation in the Rat , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[25]  Potts Dg,et al.  Toxicology of iohexol. , 1985 .

[26]  D. Potts,et al.  Toxicology of iohexol. , 1985, Investigative radiology.

[27]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[28]  R. Siraganian,et al.  IgE‐induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones , 1981, European journal of immunology.